Kalohexis, LLC· @kalohexis · X·· 2026-04-18评分60
正文 · 原文
Attending #AACR26? Stop by Poster Section 51 on April 21 to learn more about the study design of the ongoing Phase 2 Paradox trial evaluating mifomelatide for #cachexia in patients with advanced colorectal #cancer. More details here:
https://
bit.ly/41FzwsY
热度 0 · 0 赞 · 0 回复 · 0 转发
来源:Kalohexis, LLC · x.com
